MedDataX Logo

The Effectiveness of Different Techniques of Interscalene Brachial Plexus Block With General Anesthesia for Shoulder Arthroscopy

NCT ID: NCT04941235

Last Updated: 2021-06-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-05-01

Study Completion Date

2020-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There are different techniques of interscalene brachial plexus block, we aimed to evaluate the effectiveness of 3 of them as analgesia during shoulder arthroscopy surgery under general anesthesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prospective randomized controlled study

There were 4 groups included in our study:

Group N: nerve stimulator guided interscalene brachial plexus block was done Group U: ultrasound guided interscalene brachial plexus block was done Group NU: dual guidance (using both nerve stimulator and ultrasound) Group C: control group We assessed in each group: heart rate, noninvasive blood pressure, time needed for block, onset of sensory and motor power loss and their offset, and finally patient satisfaction.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Shoulder and Upper Arm Injury

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

shoulder arthroscopy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NU group

Bth nerve stimulator and ultrasound guided interscalene brachial plexus block

Group Type ACTIVE_COMPARATOR

ultrasound and nerve stimulator

Intervention Type DEVICE

nerve stimulator and ultrasound guided interscalene brachial plexus block

U group

Ultrasound guided interscalene brachial plexus block

Group Type ACTIVE_COMPARATOR

ultrasound and nerve stimulator

Intervention Type DEVICE

nerve stimulator and ultrasound guided interscalene brachial plexus block

N group

Nerve stimulator guided interscalene brachial plexus block

Group Type ACTIVE_COMPARATOR

ultrasound and nerve stimulator

Intervention Type DEVICE

nerve stimulator and ultrasound guided interscalene brachial plexus block

C group

No block only IV analgesics

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ultrasound and nerve stimulator

nerve stimulator and ultrasound guided interscalene brachial plexus block

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: 18-65 years old.
* Sex: Both sexes.
* ASA I \& II.

Exclusion Criteria

* \- Patient refusal.
* Bleeding disorders.
* Damage or disease of the brachial plexus.
* ASA more than II.
* Pre-existing peripheral neuropathy.
* Patients with neuromuscular diseases.
* Patients with known hypersensitivity to drugs of the study.
* Patients with local skin infection at the site of injection.
* Psychiatric diseases interfering with evaluation of the block.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Minia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Shery Shehata Kyriacos

Assistant Lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ahmed K Mohamed, MD

Role: STUDY_CHAIR

Professor

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Medcine

Minya, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

219:7/2019

Identifier Type: -

Identifier Source: org_study_id